Zymergen Inc. (ZY) is a publicly traded company in the Basic Materials sector, operating within the Chemicals - Specialty industry. The company is headquartered in EmeryVille, CA, United States. The current CEO is Joshua J. Hoffmann.
ZY has IPO date of 2021-04-22, 502 full-time employees, listed on the NASDAQ Global Select.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
